ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
1-Year Return
24.45%
This Quarter Return
+8.63%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$3.86B
AUM Growth
+$120M
(+3.2%)
Cap. Flow
-$142M
Cap. Flow
% of AUM
-3.67%
Top 10 Holdings %
Top 10 Hldgs %
15.38%
Holding
1,480
New
255
Increased
503
Reduced
456
Closed
248
Top Buys
| 1 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$55.9M |
| 2 |
Janus Henderson AAA CLO ETF
JAAA
|
+$39.4M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$32.5M |
| 4 |
AT&T
T
|
+$25.9M |
| 5 |
SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
|
+$25.8M |
Top Sells
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$55.9M |
| 2 |
NVIDIA
NVDA
|
+$46.9M |
| 3 |
Utilities Select Sector SPDR Fund
XLU
|
+$41.2M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$38.9M |
| 5 |
Vanguard Long-Term Bond ETF
BLV
|
+$38.5M |
Sector Composition
| 1 | Technology | 24.22% |
| 2 | Energy | 11.31% |
| 3 | Healthcare | 9.73% |
| 4 | Communication Services | 7.59% |
| 5 | Industrials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
826
DELISTED
SpringWorks Therapeutics
SWTX
| $283K | 0.01% |
5,759
+436
| +8% | +$21.5K |
|
827
Allogene Therapeutics
ALLO
$255M
| $283K | 0.01% |
63,389
+27,349
| +76% | +$122K |
|
828
BioNTech
BNTX
$24.5B
| $283K | 0.01% |
3,067
+1,827
| +147% | +$169K |
|
829
Erasca
ERAS
$462M
| $282K | 0.01% |
136,988
+82,649
| +152% | +$170K |
|
|
DCPH
830
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $282K | 0.01% |
17,909
+7,462
| +71% | +$117K |
|
831
Genmab
GMAB
$17.6B
| $281K | 0.01% |
9,404
+5,713
| +155% | +$171K |
|
832
PagSeguro Digital
PAGS
$2.74B
| $280K | 0.01% |
19,591
+3,068
| +19% | +$43.8K |
|
833
IDEAYA Biosciences
IDYA
$2.21B
| $279K | 0.01% |
6,360
+1,554
| +32% | +$68.2K |
|
834
Zymeworks
ZYME
$1.21B
| $278K | 0.01% |
26,456
+5,839
| +28% | +$61.4K |
|
835
Weatherford International
WFRD
$4.58B
| $277K | 0.01% |
+2,397
| New | +$277K |
|
836
Kura Oncology
KURA
$734M
| $277K | 0.01% |
12,963
-1,212
| -9% | -$25.9K |
|
|
AGEN
837
Agenus
AGEN
$153M
| $276K | 0.01% |
23,757
+18,406
| +344% | +$214K |
|
838
Freeport-McMoran
FCX
$64.9B
| $275K | 0.01% |
5,854
-931
| -14% | -$43.8K |
|
839
Super Micro Computer
SMCI
$26.1B
| $275K | 0.01% |
+2,720
| New | +$275K |
|
840
Caribou Biosciences
CRBU
$179M
| $273K | 0.01% |
53,160
+29,236
| +122% | +$150K |
|
841
Baker Hughes
BKR
$46.6B
| $273K | 0.01% |
8,136
+7,780
| +2,185% | +$261K |
|
842
KKR & Co
KKR
$130B
| $271K | 0.01% |
2,690
+2,657
| +8,052% | +$267K |
|
|
ARCH
843
DELISTED
Arch Resources, Inc.
ARCH
| $270K | 0.01% |
+1,682
| New | +$270K |
|
|
IGMS
844
DELISTED
IGM Biosciences
IGMS
| $270K | 0.01% |
27,935
+8,887
| +47% | +$85.8K |
|
|
CHX
845
DELISTED
ChampionX
CHX
| $268K | 0.01% |
+7,463
| New | +$268K |
|
846
Recursion Pharmaceuticals
RXRX
$2.16B
| $264K | 0.01% |
26,432
+10,073
| +62% | +$100K |
|
847
Replimune Group
REPL
$464M
| $263K | 0.01% |
32,232
+24,395
| +311% | +$199K |
|
848
Tyra Biosciences
TYRA
$650M
| $263K | 0.01% |
16,053
+6,522
| +68% | +$107K |
|
849
Arvinas
ARVN
$589M
| $263K | 0.01% |
6,372
+626
| +11% | +$25.8K |
|
850
MacroGenics
MGNX
$107M
| $261K | 0.01% |
17,742
-12,343
| -41% | -$182K |
|